Detected ·
Draig Therapeutics
$65M—
Draig Therapeutics has completed an oversubscribed $65M Series B financing round to advance its clinical portfolio of neuropsychiatric therapies, including lead candidate DT-101 for Major Depressive Disorder.
- Website
- www.draigtherapeutics.com
- Amount
- $65 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-20 16:13:19 UTC
- Signal ID
- 5bc620c2-9fae-48f6-b66f-983676534b1e
As the API returns it
{
"id": "5bc620c2-9fae-48f6-b66f-983676534b1e",
"created_at": "2026-07-20T16:13:19.494Z",
"company_name": "Draig Therapeutics",
"company_website_url": "www.draigtherapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/draigtherapeutics",
"event_type": "funding",
"funding_amount": 65000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Draig Therapeutics has completed an oversubscribed $65M Series B financing round to advance its clinical portfolio of neuropsychiatric therapies, including lead candidate DT-101 for Major Depressive Disorder.*"
}